TY - JOUR
T1 - The effect of beclomethasone-formoterol versus placebo on chronic cough in patients with non-CF bronchiectasis
T2 - the FORZA randomised-controlled trial
AU - van der Veer, Tjeerd
AU - de Koning Gans, Johanna Margaretha
AU - Braunstahl, Gerrit J.
AU - Pieters, Angelina L.P.
AU - van den Berg, Johanna M.W.
AU - Hoek, Rogier A.S.
AU - Kamphuis, Lieke S.J.
AU - Bakker, Marleen
AU - Dubois, Alain V.F.
AU - Aerts, Joachim G.J.V.
AU - van der Eerden, Menno M.
N1 - Copyright ©The authors 2023
PY - 2023/6
Y1 - 2023/6
N2 - Bronchiectasis is a chronic inflammatory condition of the airways with a high symptom burden, which includes chronic cough. The current management strategy includes identifying aetiology, comorbidity and treatable traits. The role of inhaled corticosteroids (ICS) with or without long-acting beta agonists (LABA) in treatment is uncertain. ICS use is only advised for patients with coexisting asthma or COPD. However, up to 53.1% of bronchiectasis patients use ICS or ICS/LABA, with a third having no asthma or COPD diagnosis, according to a recent EMBARC analysis (European Multicentre Bronchiectasis Audit and Research Collaboration).
AB - Bronchiectasis is a chronic inflammatory condition of the airways with a high symptom burden, which includes chronic cough. The current management strategy includes identifying aetiology, comorbidity and treatable traits. The role of inhaled corticosteroids (ICS) with or without long-acting beta agonists (LABA) in treatment is uncertain. ICS use is only advised for patients with coexisting asthma or COPD. However, up to 53.1% of bronchiectasis patients use ICS or ICS/LABA, with a third having no asthma or COPD diagnosis, according to a recent EMBARC analysis (European Multicentre Bronchiectasis Audit and Research Collaboration).
UR - https://www.scopus.com/pages/publications/85164233768
UR - https://www.researchgate.net/publication/371237840_The_effect_of_beclomethasone-formoterol_versus_placebo_on_chronic_cough_in_patients_with_non-CF_bronchiectasis_the_FORZA_randomised-controlled_trial
U2 - 10.1183/13993003.00186-2023
DO - 10.1183/13993003.00186-2023
M3 - Article
C2 - 37263749
SN - 0903-1936
VL - 61
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 6
M1 - 2300186
ER -